Skip to main content
Cyclotek banner
Cyclotek logo

Cyclotek

Cyclotek is a manufacturer of radiopharmaceuticals.

Backed by

Five V CapitalFive V Capital

EQUITY on November 6, 2023

About

Cyclotek manufactures radiopharmaceuticals and supplies them to healthcare providers across Australia and New Zealand.

Mission

Cyclotek is a radiopharmaceutical manufacturer serving the Australian and New Zealand markets. In November 2023 Five V Capital made an investment in and entered a partnership with Cyclotek. Five V Capital is a private equity and venture capital firm operating in Australia and New Zealand. Global law firm Ashurst advised Five V Capital on the investment. The Ashurst advisory team was led by partner Anton Harris and included multiple partners, senior associates and associates across Corporate Transactions, Real Estate, Digital Economy Transactions, Global Loans, Employment, IP/Media, Planning, Access and Environment, and Dispute Resolution.

Quick Facts

Founded

2001

Funding

EQUITY

Industry

Health Care, Logistics, Manufacturing, Pharmaceutical, Supply Chain Management

Team Size

51-100

Headquarters

Bundoora, Victoria, Australia